Literature DB >> 3422256

A localized vaginal allergic response in women with recurrent vaginitis.

S S Witkin1, J Jeremias, W J Ledger.   

Abstract

In women with recurring vaginitis, treatment of a vaginal Candida infection is not always accompanied by an alleviation of symptoms, and infection frequently reappears after termination of the chemotherapeutic agent. To determine whether an allergic reaction might be involved in symptom prolongation and susceptibility to reinfection, sera and vaginal washes from patients were examined for specific IgE antibodies. With RAST modified to ELISA, anti-Candida albicans IgE was identified in 18.8% of saline vaginal washes, but in only 6.1% of sera, obtained from 64 patients. Similarly, 25% of 16 patients were positive for vaginal fluid IgE, but only 6.3% had serum IgE to their partners' seminal fluid. The detection of specific IgE antibodies vaginally but not in the peripheral circulation suggested the occurrence of a localized vaginal hypersensitivity response. Vaginal fluid-derived IgE antibodies reactive with contraceptive spermicides or present in the particulate fraction of saline vaginal washes were also identified. Vaginal fluids with IgE antibodies also contained detectable levels of prostaglandin E2. A vaginal allergic response can predispose to recurrent Candida infection by inducing prostaglandin E2 synthesis that suppresses cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422256     DOI: 10.1016/0091-6749(88)90909-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

1.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

Review 2.  Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Authors:  P L Fidel
Journal:  Adv Dent Res       Date:  2011-04

3.  Association between atopy and recurrent vaginal candidiasis.

Authors:  N A Neves; L P Carvalho; M A M De Oliveira; P C Giraldo; O Bacellar; A A Cruz; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 4.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.

Authors:  M C Noverr; S M Phare; G B Toews; M J Coffey; G B Huffnagle
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans.

Authors:  A Kalo-Klein; S S Witkin
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

7.  A mechanism for the induction of type 2 immune responses by a protease allergen in the genital tract.

Authors:  Ji Eun Oh; Dong Sun Oh; Hi Eun Jung; Heung Kyu Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

Review 8.  Immunopathogenesis of recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 9.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

10.  Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans.

Authors:  Mohammed A S Alem; L Julia Douglas
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.